| Serial Number | 88862249 |
| Word Mark | GFCAS12 |
| Filing Date | Tuesday, April 7, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 11, 2021 |
| Registration Number | 6344786 |
| Registration Date | Tuesday, May 11, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 23, 2021 |
| Goods and Services | Veterinary diagnostic reagents for use in veterinary genetic testing; Diagnostic preparations for veterinary purposes; Enzymes for medical purposes for genome editing-based therapy; Genome editing-based treatment preparations in the nature of preparations for detecting mutation in genes for medical purposes; Protein arrays for medical diagnostic purposes; Biological preparations for the treatment of cancers, rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, diabetes, multiple sclerosis, heart attack, systemic lupus erythematous, age-related macular degeneration, diabetic retinopathy, prevention of pneumonia, anemia, chronic migraine, hepatitis B, hemophilia, respiratory syncytial virus (RSV) prophylaxis, HPV prevention, varicella virus vaccine, growth hormone deficiency, osteoporosis, allergic asthma, chronic idiopathic urticaria, infertility, prevention of meningococcal disease, cystic fibrosis, paroxysmal nocturnal hemoglobinuria, autoimmune diseases infectious diseases for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Cells for medical purposes; Reagents for use in medical genetic testing; Stem cells for medical purposes; Diagnostic preparations for medical purposes; Medicinal protein in the nature of protein arrays for medical diagnostic purposes; Medicinal enzymes; Medicines for human purposes and medicines for animals in the nature of medicines for cancers, rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, diabetes, multiple sclerosis, heart attack, systemic lupus erythematous, age-related macular degeneration, diabetic retinopathy, prevention of pneumonia, anemia, chronic migraine, hepatitis B, hemophilia, respiratory syncytial virus (RSV) prophylaxis, HPV prevention, varicella virus vaccine, growth hormone deficiency, osteoporosis, allergic asthma, chronic idiopathic urticaria, infertility, prevention of meningococcal disease, cystic fibrosis, paroxysmal nocturnal hemoglobinuria, autoimmune diseases, infectious diseases; Surgical implants grown from stem cells in the nature of surgical implants comprised of living tissue; Pharmaceutical preparations for genome editing-based therapy of rare inherited disorders; Ferments for medical or veterinary use; Preparations for detecting mutation in genes for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Enzymes for medical purposes |
| Pseudo Mark | GFCAS TWELVE; GFCAS ONE TWO |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 14, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | G+FLAS Life Sciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08790 KR |
| Party Name | G+FLAS Life Sciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08790 KR |
| Party Name | G+FLAS Life Sciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08790 KR |
| Event Date | Event Description |
| Friday, April 10, 2020 | NEW APPLICATION ENTERED |
| Tuesday, April 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 13, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, May 13, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, May 13, 2020 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, May 13, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 25, 2020 | ASSIGNED TO EXAMINER |
| Thursday, July 2, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, July 2, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, July 2, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 28, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 29, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, January 16, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 23, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 11, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 11, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |